key: cord-1023095-0ee3veks
authors: Jena, Anuraag; Singh, Anupam Kumar; Kumar-M, Praveen; Sharma, Vishal; Sebastian, Shaji
title: Systematic review on failure to adhere to IBD therapies during the COVID-19 pandemic: Correct information is crucial
date: 2020-09-19
journal: Dig Liver Dis
DOI: 10.1016/j.dld.2020.09.012
sha: a050ccdfad5490469267203bae6fa9965681d368
doc_id: 1023095
cord_uid: 0ee3veks

nan

The COVID-19 pandemic has brought numerous challenges to 4 the provision of care for patients with inflammatory bowel disease 5 (IBD) including limited access to healthcare systems and drugs, 6 concerns about hospital visits and treatments and concerns about 7 safety of IBD therapies [1] [2] [3] . Adherence to therapies and follow up 8 assessments are key to maintain sustained remission in IBD. We 9 performed a systematic review to identify the frequency and rea-10 sons for the disruption of care for IBD patients and attempted to 11 identify regional differences in patterns of adherence to IBD thera-12 pies. 13 We searched the databases using PubMed and Embase on 6 Au-14 gust 2020 using the keywords inflammatory bowel disease, ulcera-15 tive colitis, Crohn disease, Crohn's disease combined using the op- reported and analysed to identify differences in the failure to ad-35 here to IBD therapies. 36 We calculated the pooled rates of failure to adhere to biolog-37 ics and overall IBD therapy for all the studies together as also the 38 rates separately for each continent. The statistical analysis was per- 

Management of IBD during the COVID-131 19 outbreak: resetting clinical priorities

The effect of the COVID-19 pandemic on the medical 134 mode of patients with inflammatory bowel disease in China

Impact of 138 COVID-19 outbreak on the care of patients with inflammatory bowel disease: a 139 comparison before and after the outbreak in South China

Challenges in the care of IBD patients during the 142 COVID-19 pandemic: report from a "Red Zone" area in Northern Italy

Prevention of COVID-19 in patients with inflammatory 145 bowel disease in Wuhan, China

AGA clinical practice update on 148 management of inflammatory bowel disease during the COVID-19 pandemic: 149 expert commentary

International organization for the study of 152 inflammatory bowel disease. Management of patients with crohn's disease and 153 ulcerative colitis during the coronavirus disease-2019 pandemic: results of an 154 international meeting

Low fre-157 quency of COVID-19 in inflammatory bowel diseases

Dig Liver Dis